NASDAQ · Healthcare · Biotechnology
Lyell Immunopharma, Inc.
LYEL
Lyell Immunopharma, Inc. CEO Lynn Seely · Market cap $448.2M.
$19.21
-0.04 · -0.21%
52w hi $45.0052w lo $7.65
Off 52w high 50.2%
86
STRONG
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
2
2 strong · 0 notable
Analyst consensus
Strong Buy
Avg PT $44.50
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Mar 06 | ARCH Venture Partners IX, LLC | Buy | 488,090 | $25.61 | +$12.50M | 86 | |
| Mar 06 | ARCH Venture Fund XIII, L.P. | Buy | 488,090 | $25.61 | +$12.50M | 86 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay